GLOBAL CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET FORECAST 2017-2025

LONDON, Sept. 19, 2017 /PRNewswire/ -- KEY FINDINGS
The Global Central Nervous System (CNS) Biomarkers market is estimated to rise at a CAGR of 10.49%, increasing its value from $3587 million to $8756 million over the forecast period of 2017-2025. Factors like funding for the research and development framework programs, increasing applications of metabolomics, genomics, bioinformatics and proteomics, and an upsurge in biomarker market are primarily driving the market growth. Also, the fact that obesity has to become a serious concern worldwide and the escalating number of public-private corporations globally are presenting the market with potential growth opportunities.

Download the full report: https://www.reportbuyer.com/product/5106695

MARKET INSIGHTS
The Global Central Nervous System (CNS) Biomarkers market is segmented on the basis of applications, end-users, and types. The various applications include drug discovery and development, diagnostic development, disease risk assessment, personalized medicine, etc. The end-users for the market comprise of patients, hospitals, diagnostic centers, eye clinics, and others. The market by type is further segmented into safety biomarker, validation biomarker, and efficacy biomarker.

REGIONAL INSIGHTS
The global Central Nervous System (CNS) Biomarkers market geographically covers areas like North America (U.S. & Canada), Asia-Pacific (India, China, Japan, rest of APAC), Europe (UK, France, Germany, Spain, Italy, Rest of Europe) and rest of the world-(Latin America, Middle East and North Africa, Rest of Africa. The North American market is predicted to grab the highest share owing to the booming US market. This boom is on account of the increasing adoption of latest technologies and ongoing research in the area. However, it is the Asia-Pacific market that is forecasted to exhibit the fastest growth over the forecast period.

COMPETITIVE INSIGHTS
Enzo Biochem, an integrated bioscience company, has been focusing on developing proprietary technologies that deals with applications like oral immune regulation, cell signaling pathway, and gene analysis technology. Another company, Thermo Fisher Scientific Inc provides products and services under five principal brands that include: Applied Bio systems, Fisher Scientific, Invitrogen, Thermo Scientific, and Unity Lab Services. The other eminent market players include Alseres Pharmaceuticals Inc, Acumen Pharmaceuticals Inc, Apitope International Avacta Group Plc, Aposense, Avid Radiopharmaceuticals Inc, Diagenic Asa, Banyan Biomarkers, EKF Diagnostics, Myriad Rbm, Inc (Subsidiary Of Myriad Genetics), Exonhit Therapeutics, and Proteome Sciences.

Central Nervous System (CNS) market is estimated to rise at a CAGR of 10.49%, increasing its value from $3587 million to $8756 million over the forecast period of 2017-2025. Factors like funding for the research and development framework programs, increasing applications of metabolomics, genomics, bioinformatics and proteomics, and an upsurge in biomarker market are primarily driving the market growth. Also, the fact that obesity has to become a serious concern worldwide and the escalating number of public-private corporations globally are presenting the market with potential growth opportunities.

MARKET INSIGHTS
The Global Central Nervous System (CNS) market is segmented on the basis of applications, end-users, and types. The various applications include drug discovery and development, diagnostic development, disease risk assessment, personalized medicine, etc. The end-users for the market comprise of patients, hospitals, diagnostic centers, eye clinics, and others. The market by type is further segmented into safety biomarker, validation biomarker, and efficacy biomarker.

REGIONAL INSIGHTS
The global Central Nervous System (CNS) market geographically covers areas like North America (U.S. & Canada), Asia-Pacific (India, China, Japan, rest of APAC), Europe (UK, France, Germany, Spain, Italy, Rest of Europe) and rest of the world-(Latin America, Middle East and North Africa, Rest of Africa. The North American market is predicted to grab the highest share owing to the booming US market. This boom is on account of the increasing adoption of latest technologies and ongoing research in the area. However, it is the Asia-Pacific market that is forecasted to exhibit the fastest growth over the forecast period.

COMPETITIVE INSIGHTS
Enzo Biochem, an integrated bioscience company, has been focusing on developing proprietary technologies that deals with applications like oral immune regulation, cell signaling pathway, and gene analysis technology. Another company, Thermo Fisher Scientific Inc provides products and services under five principal brands that include: Applied Bio systems, Fisher Scientific, Invitrogen, Thermo Scientific, and Unity Lab Services. The other eminent market players include Alseres Pharmaceuticals Inc, Acumen Pharmaceuticals Inc, Apitope International Avacta Group Plc, Aposense, Avid Radiopharmaceuticals Inc, Diagenic Asa, Banyan Biomarkers, EKF Diagnostics, Myriad Rbm, Inc (Subsidiary Of Myriad Genetics), Exonhit Therapeutics, and Proteome Sciences.

Download the full report: https://www.reportbuyer.com/product/5106695

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com